|
Aug 1
|
Compared to Estimates, Qiagen (QGEN) Q2 Earnings: A Look at Key Metrics
|
|
Jul 31
|
Qiagen (QGEN) Tops Q2 Earnings and Revenue Estimates
|
|
Jul 31
|
Qiagen: Q2 Earnings Snapshot
|
|
Jul 31
|
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
|
|
Jul 25
|
Ultragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
|
Jun 27
|
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
|
|
May 16
|
Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
|
|
Apr 9
|
QIAGEN N.V. to release results for Q1 2024 and hold webcast
|
|
Apr 4
|
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
|
|
Apr 3
|
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
|
|
Jan 15
|
Those who invested in Qiagen (NYSE:QGEN) five years ago are up 22%
|
|
Jan 12
|
QIAGEN (QGEN) Wins FDA Clearance for NeuMoDx CT/NG Assay
|
|
Jan 11
|
QIAGEN N.V. to release results for Q4 2023 and hold webcast
|
|
Jan 10
|
Sarepta Therapeutics (SRPT) Surges 16.7%: Is This an Indication of Further Gains?
|
|
Dec 4
|
Estimating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)
|
|
Dec 1
|
Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?
|
|
Nov 30
|
DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy
|
|
Nov 30
|
Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report?
|
|
Nov 29
|
Qiagen (QGEN) Up 9.9% Since Last Earnings Report: Can It Continue?
|
|
Oct 18
|
Here's Why You Should Retain QIAGEN (QGEN) Stock for Now
|